Abbott Laboratories Goodwill and Intangible Assets 2010-2025 | ABT

Abbott Laboratories goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Abbott Laboratories goodwill and intangible assets for the quarter ending June 30, 2025 were $29.872B, a 4.06% decline year-over-year.
  • Abbott Laboratories goodwill and intangible assets for 2024 were $29.755B, a 8.43% decline from 2023.
  • Abbott Laboratories goodwill and intangible assets for 2023 were $32.494B, a 2.28% decline from 2022.
  • Abbott Laboratories goodwill and intangible assets for 2022 were $33.253B, a 7.55% decline from 2021.
Abbott Laboratories Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $29,755
2023 $32,494
2022 $33,253
2021 $35,970
2020 $38,528
2019 $40,220
2018 $42,196
2017 $45,493
2016 $12,222
2015 $15,200
2014 $16,265
2013 $15,507
2012 $24,362
2011 $25,695
2010 $28,082
2009 $19,492
Abbott Laboratories Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-06-30 $29,872
2025-03-31 $29,620
2024-12-31 $29,755
2024-09-30 $31,010
2024-06-30 $31,135
2024-03-31 $31,679
2023-12-31 $32,494
2023-09-30 $32,559
2023-06-30 $33,092
2023-03-31 $32,933
2022-12-31 $33,253
2022-09-30 $33,134
2022-06-30 $34,336
2022-03-31 $35,404
2021-12-31 $35,970
2021-09-30 $36,611
2021-06-30 $37,166
2021-03-31 $37,565
2020-12-31 $38,528
2020-09-30 $38,546
2020-06-30 $38,865
2020-03-31 $39,192
2019-12-31 $40,220
2019-09-30 $40,511
2019-06-30 $41,420
2019-03-31 $41,681
2018-12-31 $42,196
2018-09-30 $42,893
2018-06-30 $43,795
2018-03-31 $45,170
2017-12-31 $45,493
2017-09-30 $40,644
2017-06-30 $40,785
2017-03-31 $40,758
2016-12-31 $12,222
2016-09-30 $12,486
2016-06-30 $15,063
2016-03-31 $15,233
2015-12-31 $15,200
2015-09-30 $15,594
2015-06-30 $15,681
2015-03-31 $15,834
2014-12-31 $16,265
2014-09-30 $16,142
2014-06-30 $15,179
2014-03-31 $15,394
2013-12-31 $15,507
2013-09-30 $15,651
2013-06-30 $15,000
2013-03-31 $15,482
2012-12-31 $24,362
2012-09-30 $24,669
2012-06-30 $24,340
2012-03-31 $25,696
2011-12-31 $25,695
2011-09-30 $27,024
2011-06-30 $28,497
2011-03-31 $28,837
2010-12-31 $28,082
2010-09-30 $28,454
2010-06-30 $24,485
2010-03-31 $25,671
2009-12-31 $19,492
2009-09-30 $18,452
2009-06-30 $18,214
2009-03-31 $17,714
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $229.514B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $155.747B 37.14
Stryker (SYK) United States $149.436B 30.42
EssilorLuxottica (ESLOY) France $144.168B 0.00
Medtronic (MDT) Ireland $117.977B 16.64
Lonza Group Ag (LZAGY) Switzerland $49.715B 0.00
Haleon (HLN) United Kingdom $43.412B 24.82
ResMed (RMD) United States $41.845B 29.93
GE HealthCare Technologies (GEHC) United States $34.055B 16.01
Agilent Technologies (A) United States $33.846B 22.07
Koninklijke Philips (PHG) Netherlands $26.577B 17.58
Terumo (TRUMY) Japan $26.206B 31.05
Insulet (PODD) United States $23.159B 77.59
Zimmer Biomet Holdings (ZBH) United States $21.260B 13.53
Smith & Nephew SNATS (SNN) United Kingdom $16.271B 0.00
Baxter (BAX) United States $12.615B 9.75
Sunny Optical Technology (SNPTF) China $10.800B 0.00
Demant (WILYY) Denmark $8.121B 0.00
Bio-Rad Laboratories (BIO) United States $8.048B 29.56
Lantheus Holdings (LNTH) United States $3.819B 10.32
Envista Holdings (NVST) United States $3.510B 24.56
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Perrigo (PRGO) Ireland $3.272B 8.17
Prestige Consumer Healthcare (PBH) United States $3.231B 14.34
ICU Medical (ICUI) United States $3.106B 21.15
Haemonetics (HAE) United States $2.661B 11.88
LeMaitre Vascular (LMAT) United States $2.209B 47.38
Acuren (TIC) United States $2.126B 0.00
Curaleaf Holdings (CURLF) Canada $2.005B 0.00
AtriCure (ATRC) United States $1.881B 0.00
QuidelOrtho (QDEL) United States $1.877B 11.82
Green Thumb Industries (GTBIF) United States $1.869B 80.25
Tilray Brands (TLRY) Canada $1.530B 0.00
Phibro Animal Health (PAHC) United States $1.295B 16.55
AdaptHealth (AHCO) United States $1.249B 17.75
BioLife Solutions (BLFS) United States $1.229B 2565.00
Neogen (NEOG) United States $1.216B 19.31
InMode (INMD) Israel $0.921B 8.52
Kestra Medical Technologies (KMTS) United States $0.910B 0.00
Valneva SE (VALN) France $0.802B 0.00
Cresco Labs (CRLBF) United States $0.648B 0.00
SNDL (SNDL) Canada $0.631B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.613B 0.00
Verano Holdings (VRNOF) United States $0.593B 0.00
ZimVie (ZIMV) United States $0.535B 20.61
Surmodics (SRDX) United States $0.505B 0.00
Evolus (EOLS) United States $0.481B 0.00
VAREX IMAGING (VREX) United States $0.473B 16.29
CeriBell (CBLL) United States $0.419B 0.00
Owens & Minor (OMI) United States $0.396B 3.51
Sanuwave Health (SNWV) United States $0.366B 0.00
Canopy Growth (CGC) Canada $0.345B 0.00
TerrAscend (TSNDF) Canada $0.331B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.317B 0.00
Capricor Therapeutics (CAPR) United States $0.302B 0.00
Omeros (OMER) United States $0.296B 0.00
Aurora Cannabis (ACB) Canada $0.295B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
Brainsway (BWAY) Israel $0.290B 59.08
High Tide (HITI) Canada $0.283B 0.00
Viemed Healthcare (VMD) United States $0.275B 20.85
TriSalus Life Sciences (TLSI) United States $0.246B 0.00
Cerus (CERS) United States $0.245B 0.00
Vireo Growth (VREOF) United States $0.243B 0.00
OraSure Technologies (OSUR) United States $0.230B 0.00
Organigram Global (OGI) Canada $0.219B 0.00
Quanterix (QTRX) United States $0.217B 0.00
Exagen (XGN) United States $0.217B 0.00
Utah Medical Products (UTMD) United States $0.193B 16.13
FitLife Brands (FTLF) United States $0.171B 21.05
Biote (BTMD) United States $0.160B 5.30
Jushi Holdings (JUSHF) United States $0.142B 0.00
Jin Medical (ZJYL) China $0.133B 0.00
Quipt Home Medical (QIPT) United States $0.113B 0.00
MacroGenics (MGNX) United States $0.104B 0.00
Fonar (FONR) United States $0.095B 12.31
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.078B 0.00
Agape ATP (ATPC) $0.066B 0.00
Safety Shot (SHOT) United States $0.066B 0.00
Cytosorbents (CTSO) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 32.03
Veru (VERU) United States $0.051B 0.00
Zynex (ZYXI) United States $0.051B 0.00
Rockwell Medical (RMTI) United States $0.045B 0.00
Nephros (NEPH) United States $0.044B 34.92
Modular Medical (MODD) United States $0.042B 0.00
United-Guardian (UG) United States $0.037B 14.36
Trinity Biotech (TRIB) Ireland $0.028B 0.00
Senestech (SNES) United States $0.023B 0.00
INLIF (INLF) $0.018B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Sharps Technology (STSS) United States $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00